Transplantation, HomologousStem Cell TransplantationHematopoietic Stem Cell TransplantationStem CellsGraft vs Host DiseaseTransplantation ConditioningAntineoplastic Combined Chemotherapy ProtocolsHematologic NeoplasmsHematopoietic Stem CellsTreatment OutcomeTransplantation ChimeraGraft vs Leukemia EffectBone Marrow TransplantationEmbryonic Stem CellsGraft vs Tumor EffectPeripheral Blood Stem Cell TransplantationVidarabineBusulfanCombined Modality TherapyRecurrenceChemotherapy, AdjuvantAdult Stem CellsMyeloablative AgonistsRemission InductionTissue DonorsTransplantation, AutologousAntineoplastic AgentsLeukemia, Myeloid, AcuteCyclophosphamideSurvival AnalysisDisease-Free SurvivalLeukemiaPluripotent Stem CellsCytomegalovirus InfectionsHistocompatibility TestingLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSurvival RateLymphocyte TransfusionSalvage TherapyMinor Histocompatibility AntigensLymphocyte DepletionPrecursor Cell Lymphoblastic Leukemia-LymphomaNeoplasm, ResidualVirus ActivationStem Cell NicheSiblingsImmunosuppressive AgentsGraft SurvivalHematopoietic Stem Cell MobilizationMyelodysplastic SyndromesMultiple MyelomaNeural Stem CellsInduced Pluripotent Stem CellsCell DifferentiationPrognosisTime FactorsT-LymphocytesWhole-Body IrradiationAntilymphocyte SerumRetrospective StudiesCytomegalovirusMultipotent Stem CellsMesenchymal Stem Cell TransplantationTrans Fatty AcidsMesenchymal Stromal CellsChimerismHistocompatibilityPrimary MyelofibrosisAcute DiseaseRoseolovirus InfectionsFollow-Up StudiesStem Cell FactorCytarabineLeukemia, Myeloid, Accelerated PhaseAnemia, AplasticMelphalanBenzamidesAntigens, CD34EtoposideCells, CulturedCisplatinHepatic Veno-Occlusive DiseaseGranulocyte Colony-Stimulating FactorAntibodies, NeoplasmBone Marrow CellsLeukemia, MyeloidFlow CytometryFusion Proteins, bcr-ablCell ProliferationCord Blood Stem Cell TransplantationPyrimidinesHematologic DiseasesDoxorubicinReceptors, Purinergic P2X5Hodgkin DiseaseCell LineagePiperazinesImmunocompromised HostAntibodies, MonoclonalMice, Inbred C57BL